Product Information
TRI-LO-MILI TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1083 per EA under NDC 65862077885. Its NADAC has been published 366 times since Aug 21, 2019.
FDA first approved this application on Nov 4, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Aurobindo Pharma LimitedNDC
65862077885
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA205762FDA Approved
11/4/2016
TE Code
AB
On Market Since
11/4/2016
Price Statistics
The NADAC for TRI-LO-MILI TABLET has been published 366 times since Aug 21, 2019, and over the history we have for it it has declined 53.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1083 per EA |
|---|---|
| All-time high | $0.2410 (Dec 11, 2019) |
| All-time low | $0.0903 (Nov 20, 2024) |
| 52-week high | $0.1148 |
| 52-week low | $0.1046 |
| Median price | $0.1578 |
| Average price | $0.1537 |
| Largest weekly change | -27.8% (Apr 17, 2024) |
| Weeks tracked | 366 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRI-LO-MILI TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRI-LO-MILI TABLET, manufactured by Aurobindo Pharma Limited, is $0.1083 per EA (NDC 65862077885), effective Aug 19, 2026.
How has the price of TRI-LO-MILI TABLET changed over time?
Over the history we have for it, the NADAC for TRI-LO-MILI TABLET has declined 53.2%. It has been tracked across 366 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for TRI-LO-MILI TABLET?
Since Aug 21, 2019, the NADAC for TRI-LO-MILI TABLET has ranged from a low of $0.0903 (Nov 20, 2024) to a high of $0.2410 (Dec 11, 2019), with a median of $0.1578 per EA.
Are there cheaper alternatives to TRI-LO-MILI TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRI-LO-MILI TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TRI-LO-MILI TABLET?
TRI-LO-MILI TABLET (NDC 65862077885) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.